Imerys (NK) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 revenue reached €835 million, up 0.7% year-over-year at constant exchange rates, driven by volume growth and steady pricing despite significant currency headwinds of €40–42 million or about 5% of sales.
Adjusted EBITDA was €118 million, up 4% at constant FX, reflecting solid execution, volume increases, and cost control.
Project Horizon, a key cost-saving initiative, is on track to deliver €50–60 million in annual savings versus the 2025 cost base, with over 50% of benefits expected in 2026.
A binding agreement was announced to acquire Great Lakes Minerals, a U.S. industrial minerals processor with $80 million in sales, expected to close in H1 2026 and strengthen the US market position.
The EMILI lithium project advanced with a €50 million minority investment from the French State.
Financial highlights
Adjusted EBITDA margin for Q1 2026 was 14.2%.
On a reported basis, EBITDA decreased 7.5–8% year-over-year due to a €14 million negative FX impact.
Net income, Group share, was €1 million, down from €23 million in Q1 2025, mainly due to restructuring costs and higher financial expenses.
Current operating income declined 18.6% year-over-year to €46 million.
Financial expenses increased following a €600 million bond issued in November; net financial result was negative at €18 million.
Outlook and guidance
No quantitative 2026 guidance provided; guidance typically given at mid-year for better visibility.
Energy, raw materials, and logistics costs are expected to rise for the remainder of the year, but price increases and further actions are being implemented to offset these and protect profitability.
The group is well hedged for energy costs in Q2 and Q3 (50–60% hedged), with a potential 10–20% increase in the energy bill, but expects to cover this with price increases.
The main uncertainty is the indirect macroeconomic impact of the prolonged Middle East conflict.
April trading is in line with March, with no significant drop in activity.
Latest events from Imerys
- All resolutions passed amid stable revenues, cost-saving plans, and strategic project updates.NK
AGM 202612 May 2026 - Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 202520 Feb 2026 - Strong 2024 results, higher dividend, strategic progress, and all resolutions approved.NK
AGM 20253 Feb 2026 - H1 2024 adjusted EBITDA rose 11% to €384m, margin 20%, with strong cash flow and guidance.NK
H1 20242 Feb 2026 - Nine-month EBITDA margin rose to 19.2% as full-year guidance is confirmed.NK
Q3 202417 Jan 2026 - Organic growth and sustainability progress offset margin pressure from joint venture declines.NK
Q1 202524 Dec 2025 - Organic growth, margin expansion, and strong ESG progress with robust 2025 outlook.NK
H2 202415 Dec 2025 - Stable H1 2025 sales and EBITDA, but net income fell; full-year EBITDA guidance reaffirmed.NK
Q2 202516 Nov 2025 - Revenue down 0.7% YTD; cost controls and strategic growth moves support profitability.NK
Q3 20251 Nov 2025